Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and n-vinyl-2-pyrrolidinone

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with n-vinyl-2-pyrrolidinone in 2 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(n-vinyl-2-pyrrolidinone)
Trials
(n-vinyl-2-pyrrolidinone)
Recent Studies (post-2010) (n-vinyl-2-pyrrolidinone)
9,1561875527,5332282,213

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Lamee, KG; Bamford, CH; Middleton, IP1
Casale, TB; Erger, RA; Rozell, MD1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and n-vinyl-2-pyrrolidinone

ArticleYear
Polymeric inhibitors of platelet aggregation. II. Copolymers of dipyridamole and related drugs with N-vinylpyrrolidone.
    Biochimica et biophysica acta, 1987, Apr-16, Volume: 924, Issue:1

    Topics: Adenosine Diphosphate; Dipyridamole; Humans; Kinetics; Mass Spectrometry; Mopidamol; Platelet Activating Factor; Platelet Aggregation; Polymers; Povidone; Structure-Activity Relationship

1987
Eosinophils isolated by magnetic cell sorting respond poorly to lipid chemoattractants.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1999, Volume: 83, Issue:2

    Topics: Blood Donors; Chemotactic Factors; Chemotaxis; Dose-Response Relationship, Drug; Endothelium, Vascular; Eosinophils; Humans; Immunomagnetic Separation; Leukotriene B4; Platelet Activating Factor; Povidone; Silicon Dioxide; Umbilical Veins

1999